Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

89 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II study of combined chemoradiotherapy for limited disease-small-cell lung cancer.
Ishihara S, Tsuchiya S, Minato K, Watanabe S, Sunaga N, Sato K, Kobayashi G, Hoshino H, Naruse I, Makimoto T, Nomoto T, Takei Y, Fueki N, Takise A, Saito R, Mori M. Ishihara S, et al. Among authors: naruse i. Am J Clin Oncol. 2000 Apr;23(2):197-202. doi: 10.1097/00000421-200004000-00018. Am J Clin Oncol. 2000. PMID: 10776984 Clinical Trial.
CYFRA 21-1: an indicator of survival and therapeutic effect in lung cancer.
Takei Y, Minato K, Tsuchiya S, Takise A, Nakano H, Ezawa K, Fueki N, Hoshino H, Naruse I, Nomoto T, Makimoto T, Ishihara S, Saito R, Mori M. Takei Y, et al. Among authors: naruse i. Oncology. 1997 Jan-Feb;54(1):43-7. doi: 10.1159/000227660. Oncology. 1997. PMID: 8978592
A phase II study of afatinib treatment for elderly patients with previously untreated advanced non-small-cell lung cancer harboring EGFR mutations.
Imai H, Kaira K, Suzuki K, Anzai M, Tsuda T, Ishizuka T, Kuwako T, Naruse I, Nemoto K, Uchino J, Morozumi N, Ishihara S, Minato K, Hisada T. Imai H, et al. Among authors: naruse i. Lung Cancer. 2018 Dec;126:41-47. doi: 10.1016/j.lungcan.2018.10.014. Epub 2018 Oct 13. Lung Cancer. 2018. PMID: 30527191 Clinical Trial.
An Exploratory Randomized Phase II Trial Comparing CDDP Plus S-1 With Bevacizumab and CDDP Plus Pemetrexed With Bevacizumab Against Patients With Advanced Non-squamous Non-small Cell Lung Cancer.
Kaira K, Imai H, Souma R, Sakurai R, Miura Y, Sunaga N, Kasahara N, Tsukagoshi Y, Koga Y, Kitahara S, Kotake M, Minato K, Naruse I, Fukushima Y, Hisada T, Ishizuka T. Kaira K, et al. Among authors: naruse i. Anticancer Res. 2019 May;39(5):2483-2491. doi: 10.21873/anticanres.13368. Anticancer Res. 2019. PMID: 31092443 Clinical Trial.
89 results